National Academies of Sciences%2c Engineering%2c and Medicine

Medical Countermeasures - Expanding Delivery and Increasing Uptake Through Public-Private Partnerships: A Workshop Series

The National Academies will host a series of virtual public workshops to examine lessons learned and future opportunities for public-private partnerships to facilitate delivery, monitoring, uptake, ...
National Academies of Sciences%2c Engineering%2c and Medicine

The Nation's Medical Countermeasure Stockpile: Opportunities to Improve the Efficiency, Effectiveness, and Sustainability of the CDC Strategic National Stockpile: A Workshop

A two-day public workshop will explore opportunities to improve the efficiency, effectiveness, and sustainable methods used by the CDC Division of the Strategic National Stockpile (SNS) to distribute ...
Becker's Hospital Review

US reports 27-fold increase in vaccine injury claims during pandemic

A surge of vaccine and countermeasure claims hit an HHS program during the COVID-19 pandemic, and only about 26% of those claims have been processed, according to a Dec. 18 federal report. The U.S.
EurekAlert!

UM School of Medicine awarded $3.5 million in federal funding to expand medical countermeasures program

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that UMSOM faculty scientists have been selected as key contractors by the Biomedical Advanced Research and ...
News Medical

UM SOM selected to work with BARDA to develop radiologic and nuclear countermeasures

University of Maryland School of Medicine (UM SOM) Department of Radiation Oncology Chair and Professor William F. Regine, MD, FACR, FACRO, and UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced ...
Seeking Alpha

Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats

DURHAM, N.C., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (SCPX) (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...
Seeking Alpha

Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity

TORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...
The Hill

21st century health threats need optimal budgeting — health security is a national issue

Bombs, bullets and, most recently, bytes, tend to dominate our national security thinking. But bugs must also be added to that list. As Bill Gates recently warned the Munich Security Conference, a ...
Business Wire

Synedgen Receives Contract from BARDA to Develop MIIST305 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome

CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced a partnership valued at up to $119 million ...
Business Wire

Synedgen Announces $2.2 Million JWMRP Award for MIIST305 For Use as a Prophylactic Radiation Medical Countermeasure

CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced that it has been awarded a $2.2 million ...
Nasdaq

Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats

DURHAM, N.C., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO"), ...